FDA.reportPublic FDA data

salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 Actuat

RxCUI
866048
RxNorm name
salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 Actuat
Display name
salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 Actuat
Full name
salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 Actuat
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SEREVENT DISKUSSALMETEROL XINAFOATEGlaxoSmithKline LLC12d9728e-6b5c-4aee-bfb0-745e542ed2e42022-10-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 866048

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
12d9728e-6b5c-4aee-bfb0-745e542ed2e460 ACTUAT salmeterol 0.05 MG/ACTUAT Dry Powder InhalerSCD31These highlights do not include all the information needed to use SEREVENT DISKUS safely and effectively. See full prescribing information for SEREVENT DISKUS. SEREVENT DISKUS (salmeterol xinafoate inhalation powder), for oral inhalation use Initial U.S. Approval: 199420221010
12d9728e-6b5c-4aee-bfb0-745e542ed2e4salmeterol 50 MCG/INHAL Dry Powder Inhaler, 60 BistersPSN31These highlights do not include all the information needed to use SEREVENT DISKUS safely and effectively. See full prescribing information for SEREVENT DISKUS. SEREVENT DISKUS (salmeterol xinafoate inhalation powder), for oral inhalation use Initial U.S. Approval: 199420221010
12d9728e-6b5c-4aee-bfb0-745e542ed2e4salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ActuatSY31These highlights do not include all the information needed to use SEREVENT DISKUS safely and effectively. See full prescribing information for SEREVENT DISKUS. SEREVENT DISKUS (salmeterol xinafoate inhalation powder), for oral inhalation use Initial U.S. Approval: 199420221010
c4925b2c-bde1-45fd-8109-dc75bee3b7a3salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ActuatSY2These highlights do not include all the information needed to use SEREVENT DISKUS safely and effectively. See full prescribing information for SEREVENT DISKUS. SEREVENT DISKUS (salmeterol xinafoate inhalation powder) FOR ORAL INHALATION Initial U.S. Approval: 199420120927
c4925b2c-bde1-45fd-8109-dc75bee3b7a3salmeterol 50 MCG/INHAL Dry Powder Inhaler, 60 BistersPSN2These highlights do not include all the information needed to use SEREVENT DISKUS safely and effectively. See full prescribing information for SEREVENT DISKUS. SEREVENT DISKUS (salmeterol xinafoate inhalation powder) FOR ORAL INHALATION Initial U.S. Approval: 199420120927
c4925b2c-bde1-45fd-8109-dc75bee3b7a360 ACTUAT salmeterol 0.05 MG/ACTUAT Dry Powder InhalerSCD2These highlights do not include all the information needed to use SEREVENT DISKUS safely and effectively. See full prescribing information for SEREVENT DISKUS. SEREVENT DISKUS (salmeterol xinafoate inhalation powder) FOR ORAL INHALATION Initial U.S. Approval: 199420120927